Global Pharma Giants Bet Big on China’s Biotech Boom 💊🌏
Global pharmaceutical giants like Eli Lilly and AstraZeneca are pouring billions into China’s biotech sector, driven by new policies and market potential. 🚀💡
PharmaInvestments
Read More
French Pharma Giant Boosts Cancer Drug Production in China 💊🇨🇳
Pierre Fabre partners with Sinopharm to localize cancer treatments in China, aligning with the upcoming 15th Five-Year Plan. 🌍💼
AstraZeneca Bets Big on China: $700M Innovation Hub in Qingdao 🌏💊
AstraZeneca’s $700M Qingdao investment fuels China’s rise as a global innovation leader, with a focus on breakthrough inhaled medicines. 🌍💡